Inanc, N. Et Al. 2023. Unintentional Monotherapy in Rheumatoid Arthritis Patients Receiving Tofacitinib and Drug Survival Rate of Tofacitinib. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY , vol.29, no.8 , 365-369.

Inanc, N., Abacar, K. Y., ÖZTÜRK, M. A., TUFAN, A., Karadeniz, H., SARI, İ., ... CAN, G.(2023). Unintentional Monotherapy in Rheumatoid Arthritis Patients Receiving Tofacitinib and Drug Survival Rate of Tofacitinib. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY , vol.29, no.8, 365-369.

Inanc, Nevsun Et Al. "Unintentional Monotherapy in Rheumatoid Arthritis Patients Receiving Tofacitinib and Drug Survival Rate of Tofacitinib," JCR-JOURNAL OF CLINICAL RHEUMATOLOGY , vol.29, no.8, 365-369, 2023

Inanc, Nevsun Et Al. "Unintentional Monotherapy in Rheumatoid Arthritis Patients Receiving Tofacitinib and Drug Survival Rate of Tofacitinib." JCR-JOURNAL OF CLINICAL RHEUMATOLOGY , vol.29, no.8, pp.365-369, 2023

Inanc, N. Et Al. (2023) . "Unintentional Monotherapy in Rheumatoid Arthritis Patients Receiving Tofacitinib and Drug Survival Rate of Tofacitinib." JCR-JOURNAL OF CLINICAL RHEUMATOLOGY , vol.29, no.8, pp.365-369.

@article{article, author={Nevsun Inanc Et Al. }, title={Unintentional Monotherapy in Rheumatoid Arthritis Patients Receiving Tofacitinib and Drug Survival Rate of Tofacitinib}, journal={JCR-JOURNAL OF CLINICAL RHEUMATOLOGY}, year=2023, pages={365-369} }